NeOnc Technologies announced positive Phase 2a results for its intranasal NEO100 treatment in recurrent brain cancer, showing improved survival rates and no major toxicities. The company also advanced its oral NEO212 program toward Phase 2 development and secured $15 million in funding, using part to redeem preferred stock and reduce dilution. NeOnc strengthened its international presence through a collaboration with Abu Dhabi's Department of Health and plans to present clinical data at the Society for Neuro-Oncology meeting. These developments support NeOnc's goal to innovate CNS cancer therapies and expand global research partnerships.
NeOnc Technologies' recent clinical and corporate progress provides context for healthcare sector activity on Pluang. For readers following health stocks, here is Pluang's market snapshot as of Nov 05, 2026 19:42 WIB: Among 150 priced US health-sector stocks, 87 rose and 56 fell. Notable movers include Acadia Healthcare Company Inc (ACHC) at USD 34.25 with a 6.20% increase and a typical hold time of 9 days, Becton Dickinson and Co (BDX) at USD 197.10 down 5.78% with a 105-day hold time, and LifeStance Health Group Inc. (LFST) at USD 14.99 up 5.49% with a 13-day hold time.
Scout Clean Energy has announced that its 183 MW Nimbus Wind Farm in Carroll County, Arkansas, is now commercially operational after two years of construction. The wind farm, the largest in Arkansas, generates enough electricity to power over 40,000 ...
CRCAM Toulouse 31 announced the publication and filing of its financial information report for the quarter ending September 30, 2026. The report is accessible to the public on the company's website under the regulatory information section for 2026. T...
Global tech giants like Amazon, Google, and Microsoft are committing hundreds of billions of dollars to expand AI-focused data center accelerators, driven by surging demand from generative AI workloads that exceed traditional CPU capabilities. These ...
Berkshire Hathaway's stock portfolio is now worth about three times what the company originally paid for it. These gains alone represent roughly 19% of Berkshire Hathaway's total company value, highlighting the significant growth and value generated ...
C3is Inc. will implement a one-for-five reverse stock split effective November 9, 2026, reducing its outstanding shares from about 4.2 million to 0.84 million. This move aims to increase the stock price to meet Nasdaq's minimum bid price requirement ...
